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Introduction
Type 2 diabetes mellitus (T2DM) has become 
a universal public health problem as the prevalence 
dramatically escalated over the past 20 years in 
numerous parts of the world [1], [2]. The International 
Diabetes Federation (IDF) estimated that 382 million 
people had diabetes worldwide in 2013 and predicted 
that the prevalence will rise to 592 million in 2035 [2]. 
Asia is greatly affected by the rising prevalence of 
T2DM, where more than 60% of the world’s T2DM 
population are Asians [3].
Malaysia, a multi-ethnic nation consisting of 
Malays, Chinese, and Indians, is also experiencing a 
T2DM epidemic. Its prevalence among adults aged 
≥18 years old has dramatically increased from 6.3% 
in 1986, 8.3% in 1996, 11.6% in 2006, 15.2% in 
2011 to an astounding 17.5% in 2015 [4]. Numerous 
factors have contributed toward this huge upsurge 
over the past 4 decades. These include urbanization, 
industrialization, and motorization due to its fast 
economic development. Undoubtedly, these factors 
have contributed toward its population to adopt a 
more sedentary lifestyle with excessive calorie intake 
[5], [6]. The World Health Organization has projected 
that Malaysia would have a total of 2.48 million people 
with T2DM by the year 2030 compared to 0.94 million 
in 2000 [7]. Based on the disability-adjusted life years 
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Abstract
AIM: The objective of this study was to evaluate the effectiveness of the EMPOWER- participatory action research 
(PAR) intervention, a multifaceted strategy based on the chronic care model (CCM) on primary care providers (PCP)’ 
adherence to type 2 diabetes mellitus (T2DM) clinical practice guideline (CPG) in the Malaysian primary care setting.
METHODS: This was a pragmatic cluster randomized controlled trial –PAR conducted in ten public primary care 
clinics in Malaysia. Five clinics were randomly selected to provide the EMPOWER-PAR intervention for 1 year and 
another five clinics continued with usual care. The outcome measure was the absolute change in the proportion of 
PCP’s adherence to T2DM CPG captured using the “Indicators of Care Pro forma,” based on the recommendation by 
the Malaysian CPG on the Management of T2DM. Data were collected from the patients’ medical records, at baseline 
and at 1-year follow-up; and were analyzed using mixed method model.
RESULTS: A total of 888 patients were recruited at baseline; 471 were in the intervention and 417 were in the 
control group. There was no significant demographic difference between the two groups at baseline except for 
ethnicity. At 1-year, 455 (96.6%) and 406 (97.3%) patients in the intervention and control groups completed the study, 
respectively. There were significant improvements in the absolute change in the proportion of PCPs’ adherence 
to T2DM CPG in the intervention group compared to the control group at 1-year follow-up in several indicators of 
care. These included the recording of BMI (0.6% vs. −1.8%, p<0.001); performing foot examination (2.4% vs. 0.6%, 
p<0.001); performing funduscopy/fundus photography (1.5% vs. 0.3%, p<0.001); monitoring renal profile (0.9% 
vs. −0.6%, p=0.001); measuring urine protein (1.2% vs. 0.6%, p<0.001), and giving lifestyle modification and self-
management advice (1.2% vs. −0.3%, p<0.001) in the intervention versus control groups, respectively.
CONCLUSION: The EMPOWER-PAR intervention has been proven to be effective in improving the PCPs’ adherence 
to T2DM CPG in several indicators of care. Findings from this study provided objective evidence of the effectiveness 
of multifaceted intervention based on the CCM in the Malaysian public primary care setting.
TRIAL REGISTRATION: Registered with: ClinicalTrials.gov: NCT01545401. Date of registration: 1st March 2012.
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estimation, T2DM was the 9th leading cause of disease 
burden in Malaysia [8].
Clinical practice guidelines (CPG) have been 
developed to improve the quality of care by emphasizing 
key clinical recommendations based on current 
evidence, including for T2DM [9]. Evidently, adherence 
to CPG prevents complications in patients with T2DM, 
improves health-care outcomes, and reduces mortality 
and health expenditure [10]. However, adherence to 
CPG varies widely among doctors as some clinicians 
considered CPG being impractical and too rigid to apply 
to individual patients [11].
In Malaysia, several local studies have 
shown that there was poor adherence to T2DM CPG 
recommendations among primary care providers 
(PCP) [12], [13], [14]. A huge gap between CPG 
recommendations and the actual practice was evident 
in the Audit Diabetes Control and Management 
study involving 70,889 adults with T2DM at primary 
care clinics, in which a majority of patients received 
suboptimal management and had poor glycemic control 
with mean HbA1c of 8.3% [13]. A high-patient load, short 
consultation time, and cost constraint were among the 
barriers contributing to difficulties in translating CPG 
recommendations into clinical practice [15].
Health-care decision-makers have been 
seeking methods to improve the management of T2DM 
including adherence to CPG among PCP. The chronic 
care model (CCM) offers the solution to transform care 
for patients with chronic diseases including T2DM, to 
deliver high quality and patient-centered chronic disease 
care to the population [16], [17]. The application of 
CCM in managing T2DM in the Malaysian primary care 
setting can potentially maximize returns from limited 
resources by shifting from an acute to the chronic 
care approach [18]. The six elements of CCM include 
health-care organization, delivery system design, 
clinical information system, patient self-management 
support, decision support, and use of community 
resources [16], [17]. One of the CCM elements of 
interest is “decision support” which emphasizes the 
importance for providers to embed evidence-based 
guidelines into their daily clinical practice to improve 
outcomes for chronic conditions [16], [17].
The evidence on the effectiveness of one or 
more of CCM key elements in improving T2DM outcomes 
are well established in developed countries [19], [20]. 
A relatively modest clinicians’ effort to incorporate 
elements of the CCM into their daily practices was 
associated with significantly improved processes and 
outcomes of diabetes care [21]. A study in Tuscany 
shows that diabetes care indicators improved after the 
implementation of CCM [22].
In developing countries, evidence on the 
effectiveness of CCM for T2DM is emerging. A study 
in the Philippines [23] and our EMPOWER-PAR 
study [24] showed that glycemic control improved after 
CCM implementation, supporting the restructuring 
of care in limited resource settings [23], [24]. In 
the EMPOWER-PAR study, we have pragmatically 
implemented three obligatory intervention components 
which were designed based on the CCM at selected 
public primary care clinics [24], [25]. One of the 
obligatory components included utilizing the T2DM 
CPG by the PCP (decision support) [25]. Evidence of 
CCM effectiveness in improving providers’ adherence 
to clinical guidelines in developing countries is lacking. 
Therefore, the objective of this study was to evaluate 
the effectiveness of EMPOWER-PAR intervention 
in improving PCP’s adherence to T2DM CPG in the 
Malaysian public primary care setting.
Methods
Study design and participants
This was a sub-study of the EMPOWER-PAR; 
a pragmatic, cluster-randomized, parallel, matched 
pair, and controlled trial using PAR approach [24] in ten 
public primary care clinics from two states in Malaysia. 
The study protocol was registered with the clinicaltrial.
gov (NCT01545401) and was published in 2014 [25]. 
This paper reports the findings from the T2DM arm of 
the study and the reporting is done in accordance with 
the extension of CONSORT Statements on reporting 
pragmatic trials and cluster randomized trials [25].
Site selection and recruitment
All 34 public primary care clinics led by Family 
Medicine Specialists (FMS) in Selangor and Kuala 
Lumpur were invited to participate in this study. Eligibility 
of the clinics was assessed using the following criteria:
1. Had ≥ 500 patients with T2DM in the registry
2. Had an FMS who were keen to participate and 
willing to lead the team
3. Had the capacity and willing to implement the 
obligatory components of the EMPOWER-PAR 
intervention
4. Was located within 70 km from the central 
laboratory as the data and blood samples were 
transported back to the center for analysis.
Out of the 34 sites, only 20 fulfilled the 
eligibility criteria to enter the study. These 20 clinics 
were then matched according to their geographical 
locations (urban or sub-urban), workload and staffing 
into ten pairs. Clinics were matched according to these 
covariates as they were likely to affect the outcome 
variables, as the intervention was delivered at the 
cluster (clinics) level. Matching was employed before 
the randomization to ensure similarity between the 
intervention and control groups. The investigators then 
used computer generated tables to randomly select 
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five out of the ten matched-pairs to be included into 
the study. Subsequently, one clinic in each pair was 
randomly allocated into the intervention or control arms.
Patient recruitment
Consecutive T2DM patients who attended the 
clinics within the 2-week recruitment period were invited 
to participate. They were given the patient information 
sheet and interviewed by the investigators in the waiting 
area. Screening was conducted to identify eligible 
participants based on the inclusion and exclusion criteria. 
Those who agreed and were eligible to participate were 
recruited. Written informed consents were obtained.
Inclusion criteria
Adults aged ≥ 18 years who:
1. Were diagnosed with T2DM, or on treatment 
for T2DM
2. And received follow-up care for T2DM in the 
same clinic at least once in the past 1 year.
Exclusion criteria
Patients with the following criteria were 
excluded from the study:
1. Type 1 diabetes mellitus
2. Receiving renal dialysis
3. Presented with severe hypertension (HPT) 
(systolic blood pressure [BP]>180 mmHg 
and/or diastolic BP>110 mmHg) at recruitment
4. Diagnosed with conditions resulting in 
secondary HPT
5. Diagnosed with circulatory disorders requiring 
referral to secondary care over the past 1 year 
(e.g., unstable angina, heart attack, stroke, 
and transient ischemic attacks)
6. Receiving shared care at primary and 
secondary care centers for complications of 
T2DM
7. Pregnant
8. Enrolled in another study.
The EMPOWER-PAR intervention
The EMPOWER-PAR intervention was 
designed based on the six interrelated elements of 
the CCM. The details of its development have been 
described in the study protocol [25]. It consisted of three 
obligatory components and two optional components 
utilizing readily available and existing resources in the 
Malaysian public primary care setting [25]. The obligatory 
components included creating or strengthening the 
Chronic Disease Management (CDM) Team for diabetes 
care (delivery system design), utilizing the T2DM CPG 
by the CDM Team (decision support), and empowering 
patients with self-management skills through utilization 
of the Global Cardiovascular Risks Self-Management 
Booklet© (patient self-management support) [25].
Delivery of the intervention
The EMPOWER-PAR intervention was 
delivered for a period of 1-year. The intervention clinics 
received the EMPOWER-PAR intervention package, 
which consisted of CDM Workshops, T2DM CPG, 
self-management support tool, facilitation, and support.
The intervention was delivered in three phases:
Phase 1: Formation and training of the CDM 
team
CDM team members were formed by each 
intervention clinic and were then trained in the CDM 
workshops. Details of the CDM workshops development, 
objectives and content were already published in the 
protocol paper [25]. In the workshop, the CDM team 
was trained to utilize the Malaysian CPG and the 
Quick References (QR) on the Management of T2DM 
[26] to support their clinical decision-making during 
consultations. They were also trained to empower 
their T2DM patients with knowledge and skills to self-
manage their condition using the Global CV Risks Self-
Management Booklet© as a tool.
Phase 2: Distribution and utilization of the 
intervention tools
The Malaysian T2DM CPG, the QR, and the 
Global CV Risks Self-Management Booklet© were 
distributed to all the intervention clinics. The CDM 
Teams were expected to utilize these tools in their day-
to-day clinical practice.
Phase 3: Facilitation and support to 
implement the intervention
The intervention clinics received facilitation and 
support throughout the 1-year study period. Each clinic 
was assigned two facilitators to coach the CDM team, 
facilitate, and guide the implementation of intervention 
and provide feedback on their performance. Two site 
visits at 3 and 9 months were conducted over the 
1-year intervention period. The facilitators monitored 
the utilization of T2DM CPG and the Global CV Risks 
Self-Management Booklet© in each clinic to ensure 
that it was delivered as intended throughout the 1-year 
period.
An intervention review workshop was also 
conducted 6 months after the commencement of 
intervention to allow interactions among the participating 
clinics and solve any arising problems. CPG training and 
feedback with regard to their baseline clinical outcomes 
were also delivered during this workshop [25].
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The control
The control clinics continued with usual care 
with no additional intervention during the 1-year period. 
The control clinics have access to T2DM CPG as this 
is readily available on the internet. However, they did 
not receive CPG training and CPG utilization was not 
emphasized or monitored.
Outcome measures
Outcome measures were obtained from both 
intervention and control clinics at baseline and 1 year 
after the commencement of the intervention.
Primary outcome
Primary outcome was measured by the change 
in the proportion of patients achieving glycemic target 
of HbA1c <6.5% (48 mmol/mol).
Secondary outcome
Secondary outcome was the absolute change 
in the proportion of PCP’s adherence to T2DM CPG 
as captured using the “Indicators of Care Pro forma” 
based on the recommendation by the Malaysian CPG 
on the Management of T2DM [26].
Sample size
The sample size was calculated based on 
the randomized clustered trial design using the PASS 
software (Copyright (c) 2009 by Dr Jerry L. Hintze, All 
Rights Reserved). A sample size of 626 (313 in each arm) 
was obtained by sampling ten clusters (five intervention 
vs. five control) with 63 subjects from each cluster to 
achieve 91% power to detect 25% difference in the 
proportion of subjects achieving target HbA1c < 6.5% 
(as the primary outcome of this study) from baseline 
and between the intervention and control groups. The 
test statistic used was the two-sided Z-test (unpooled). 
The significance level of the test was 0.05. Therefore, 
after allowing for 25% dropout rate, this study aimed to 
recruit a total sample of 836 T2DM patients at baseline 
(i.e., 418 in each arm and 84 from each clinic).
Data collection
Socio-demographic data (age, gender, ethnic 
group, and education attainment) and data on PCP’s 
adherence to T2DM CPG were obtained from the 
medical records using the “Indicators of Care Pro 
forma” (Appendix 1) from both the intervention and 
control clinics at baseline and at 1-year follow-up. The 
pro forma was developed by the investigators to capture 
the indicators of care for T2DM as recommended by the 
Malaysian CPG on the Management of T2DM [26]. It 
consists of four sections (history; physical examinations; 
investigations; and management) with 15 indicators. 
All investigators were trained regarding the study 
procedures before the conduct of the study to minimize 
variability in the method of data collection.
Statistical analysis
Age was described as mean ± standard deviation 
(SD) in years, while categorical variables were described 
as frequencies and percentages. Independent t-test was 
used to compare the mean age between participants 
in the intervention and control groups. The Chi-square 
test was used for categorical variables to compare the 
proportion between the two groups. Mixed method model 
(random effect = the cluster; fixed effect = the intervention; 
and control groups) was used to analyze the difference in 
absolute change in the proportion of PCP’ adherence to 
T2DM CPG at baseline and at 1-year follow-up.
Results
A total of 888 participants with T2DM were 
recruited at baseline (471 were in the intervention group, 
while 417 were in the control group). Figure 1 shows the 
EMPOWER-PAR CONSORT flow diagram. The result 
on the effectiveness of EMPOWER-PAR intervention 
in improving glycemic control (the primary outcome of 
this study) has already been published [24]. Therefore, 
this paper presents the result on the effectiveness 
of EMPOWER-PAR intervention in improving CPG 
adherence among PCP (secondary outcome).
Table 1 shows baseline socio-demographic 
characteristics of the participants. The two groups were 
comparable in terms of mean age, gender distribution, 
and education attainment. However, there was a 
significant difference in terms of ethnic distribution 
between the two groups in which there were more 
Malays in the intervention (51.4%) versus control 
(45.7%) and less Chinese in the intervention (15.1%) 
versus control (21.6%) groups.
Table 1: Demographic characteristics of participants with 
T2DM (n=888)
Characteristics Intervention (n=471) Control (n=417) p-value
Age, years; mean (± SD) 57.3 (± 10.2) 57.9 (± 10.5) 0.363ψ
Gender; n (%) 0.444γ
Male 180 (38.2) 149 (35.7)
Female 291 (61.8) 268 (64.3)
Ethnicity; n (%) 0.010γ
Malay 242 (51.4) 190 (45.7)
Chinese 71 (15.1) 90 (21.6)
Indian 157 (33.3) 130 (31.3)
Other 1 (0.2) 6 (1.4)
Missing 0 1(0)
Education attainment; n (%) 0.359γ
Primary 187 (41.1) 157 (39.4)
Secondary 197 (43.3) 192 (48.2)
Tertiary 37 (8.1) 23 (5.8)
None 34 (7.5) 26 (6.5)
Missing 16 (0) 19 (0)
ψIndependent t-test, γChi-square, p<0.05.
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Table 2 shows the comparison of absolute 
change in the indicators of care at 1-year follow-up 
between the intervention and control groups. There 
were significant improvements in the absolute change 
in the proportion of PCP’ adherence for recording 
of BMI (0.6% vs. −1.8%, p < 0.001); performing foot 
examination (2.4% vs. 0.6%, p < 0.001); performing 
funduscopy/fundus photography (1.5% vs. 0.3%, 
p < 0.001); monitoring renal profile (0.9% vs. −0.6%, 
p = 0.001); measuring urine protein (1.2% vs. 0.6%, 
p < 0.001), and giving lifestyle modification and self-
management advice (1.2% vs. −0.3%, p < 0.001) in 
the intervention group compared to the control group 
at 1-year follow-up. However, there was significant 
improvement in the absolute change in the proportion 
of PCP’ adherence for performing ECG (0.6% vs. 
−0.9%, p = 0.002) in the control group compared to the 
intervention group at 1-year follow-up.
Figure 1: The EMPOWER-participatory action research consort flow diagram
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Discussion
The complexity of T2DM management 
remains a challenge to PCP, despite the availability 
of established treatment standards and clinical 
guidelines [27]. The burgeoning burden of T2DM in 
Malaysia is taking its toll on the primary care workforce, 
resulting in sub-optimal management of the condition 
with evidence showing poor adherence to T2DM 
CPG among PCP [6], [13], [14]. The EMPOWER-
PAR was the first pragmatic randomized-controlled 
trial conducted in the Malaysian public primary care 
setting using resources which were readily available 
within the public primary care system with the aim 
to improve the adherence to T2DM CPG [25]. Its 
multifaceted interventions were conceptualized based 
on the CCM, which had been proven to be effective in 
improving providers’ adherence to CPG in developed 
countries [28], [29], [30].
The EMPOWER-PAR was unique in its 
design as it utilized a pragmatic cluster randomized 
trial design, which is expected to measure the degree 
of beneficial effect of the intervention in real life clinical 
practice. In pragmatic trials, a balance between 
external validity (generalizability of the results) and 
internal validity (reliability or accuracy of the results) 
needs to be achieved [31]. In this study, the roles 
of PCP in the CDM team were strengthened, while 
reinforcing the adherence to T2DM CPG to support 
evidence based decision-making, and enhancing their 
skills to support patients’ self-management. Flexibility 
on the implementation of the intervention was also 
allowed in line with the needs and constraints of the 
clinics.
We found that there were significant 
improvements in the absolute change in the 
proportion of PCPs’ adherence to T2DM CPG in 
the intervention group with regard to the recording 
of BMI, performing foot examination, performing 
funduscopy/fundus photography, monitoring renal 
profile, measuring urine protein, and giving lifestyle 
modification and self-management advice. These 
findings were similar to a randomized controlled 
trial involving 504 patients (278 patients in the 
intervention practices and 226 patients in the control 
practices) which showed that the mean results of 
three annual performance measures (urine protein 
testing, funduscopy, and foot examination) had 
improved at 18-month follow-up in the intervention 
group as compared to the control group [32]. Another 
study of 208 patients showed that 85.5% had more 
than twice HbA1c test done in a year, 93.6% had 
lipid profiles test, and 100% had foot examinations 
following a multifaceted intervention [33].
Our study has added to the body of evidence 
that multifaceted interventions targeted at physicians 
and organization is proven to enhance physicians’ 
adherence to the recommended process of care. 
A systematic review of interventions to improve the 
adherence to cardiovascular disease guidelines 
described similar findings [34]. Another study in 
rural Kenya also found that providers’ adherence to 
clinical guidelines increased significantly across all 
process measures with implementation of multifaceted 
intervention strategies [35]. A study in Turkey also 
observed improvements in the processes of T2DM 
care with multifaceted intervention, but no immediate 
improvement was seen in glycemic control or risk 
factors for chronic complications of T2DM [36]. All of 
these findings support the importance of multifaceted 
intervention, which include training PCP to utilize 
evidence-based guidelines (decision support) to 
improve indicators of care and clinical outcomes.
Table 2: Comparison of absolute change in the proportion of PCP’s adherence to indicators of care at 1-year follow-up between 
control and intervention groups
Indicators of care Intervention Absolute
change (%)
Control Absolute
change (%)
*p value
Baseline (%) Follow-up (%) Baseline (%) Follow-up (%)
History
1.  Family history of premature CVD recorded  once since 
diagnosis
100 100 0.00 100 100 0.00 NA
2.  Smoking status recorded at least once in the last 1 year 6.6 5.4 -1.2 5.4 4.5 -0.9 < 0.001
3.  The presence/absence of erectile dysfunction was screened 
and recorded in adult males over the age of 40 years
1.5 1.8 0.3 0.0 0.0 - < 0.001
Physical Examinations
4.  BP was recorded at each visit 100 100 0.00 100 100 0.00 NA
5.  BMI was recorded at least once in the last 1 year 19.3 19.9 0.6 17.5 15.7 -1.8 < 0.001
6.  WC was recorded at least once in the last 1 year 15.7 16.3 0.6 15.4 14.8 -0.6 0.855
7.  Foot examination was performed at least once in the last 
1 year
18.4 20.8 2.4 17.8 18.4 0.6 < 0.001
Investigation
8.  FSL was measured at least once in the last 1 year 22.0 21.7 -0.3 19.3 17.8 -1.5 < 0.001
9. HbA1c was measured every 6-12 months 60.8 61.7 0.9 60.8 60.5 -0.3 0.152
10.  Funduscopy/fundus photography was sperformed at least 
once in the last 1 year
19.3 20.8 1.5 17.8 18.1 0.3 < 0.001
11.  ECG was performed at least once in the  last 1 year 13.9 13.0 -0.9 11.4 12.0 0.6 0.002
12.  RP was measured at least once in the  last 1 year 20.8 21.7 0.9 19.6 19.0 -0.6 0.001
13.  Urine protein was measured at least  once in the last 1 year 65.4 66.6 1.2 66.6 67.2 0.6 < 0.001
Management
14.  The interval between follow up visits did not exceed 6 
months within the last 1  year
100 100 0.00 100 100 0.00 NA
15.  Lifestyle modification and self-management advice was 
given and  recorded at least once in the last 1 year 
5.7 6.9 1.2 6.3 6.0 -0.3 < 0.001
*Mixed method model, random effect was the cluster; fixed effect was the intervention and control groups. P value of <0.05 indicated significant difference in the proportion of absolute change in PCP’s adherence to indicators 
of care at 1-year follow-up between control and intervention groups.
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This study also highlights the importance of 
PAR approach to promote adherence to CPG among 
PCP. Providers in this study were involved in designing 
the “Indicators of Care Pro forma” and giving their 
feedback on which indicators that were most important 
to improve the management of T2DM. The PAR 
approach empowered the PCP to contribute actively 
in the development of indicators of care, and also in 
making the plans of actions on how best to implement 
the intervention within their constraints.
The EMPOWER-PAR intervention which 
applied the CCM concept and the PAR approach 
has helped to improve the understanding on the 
complexity of the system and human factors which 
influenced adherence to CPG. Much of the previous 
research on CPG implementation has attempted to 
study the individual factors that were associated with 
success or failure of CPG utilization [37], [38]. The 
EMPOWER-PAR has broadened our understanding of 
CPG implementation at the patient and health-care unit 
levels.
Study limitations
Monitoring the intervention and ensuring 
its implementation posed a great challenge to the 
researchers in this study. It required multiple visits and 
encounters with PCP in the intervention clinics to ensure 
that the intervention was delivered as intended. Some 
of the intervention clinics faced constraints such as high 
staff turnover, high workload, and limited consultation 
time.
Implications for clinical practice and future 
research
The EMPOWER-PAR has demonstrated that 
multifaceted intervention based on the CCM was 
effective in improving the PCP’ adherence to T2DM 
CPG in several indicators of care in a resource-
constrained public primary care setting. Our previous 
publication has also shown that EMPOWER-PAR 
was effective in improving glycemic control [24]. This 
information would be pivotal in guiding the health-
care professionals and policy makers to make the 
necessary changes to the chronic disease delivery 
system, to ensure that patients are satisfied with the 
care that they receive.
However, given the constraints in the 
Malaysian public primary clinics such as high staff 
turnover, further research which includes a longer 
duration of intervention is needed to evaluate the 
sustainability of the intervention and its effectiveness. 
Future research may also include cost-effectiveness 
analysis of implementing the multifaceted intervention 
in the Malaysian primary care setting.
Conclusions
The EMPOWER-PAR intervention has 
been proven to be effective in improving the PCPs’ 
adherence to T2DM CPG in several indicators of care. 
Findings from this study provided objective evidence of 
the effectiveness of multifaceted intervention based on 
the CCM using PAR approach in the Malaysian public 
primary care setting.
Ethics approval and consent to participate
The Ethics Committee of UiTM and the 
Medical Research Ethics Committee of the Ministry of 
Health (MOH), Malaysia approved the study protocol. 
Permission from the Family Health Development 
Division of the MOH and the respective Health District 
Offices was also obtained before the conduct of the 
study. Written informed consent was obtained from all 
participants before their study enrolment. Confidentiality 
of personal information was ensured at all times. 
Enrolment was done by the investigators and not the 
participants’ attending doctors to reduce participants’ 
perceived coercion to participate in the study.
Availability of data and materials
Technical appendix, statistical code, and 
dataset of this study is kept in secure database at 
the Institute of Pathology, Laboratory and Forensic 
Medicine (I-PPerForM), UiTM and at the Clinical 
Research Centre, MOH in Kuala Lumpur, Malaysia. 
Data can be shared on request and it is subjected to 
the data protection regulations.
Author’s Contribution
ASR and JH conceptualized and designed 
the study. ASR and JH acquired the funding and 
coordinated the study. MHD, NKBMH, and SL made 
substantial contributions to the acquisition of data and 
monitoring the implementation of the intervention. MHD 
and TMITABS analyzed and interpreted the data. MHD, 
ASR, and SAR drafted the manuscript. All authors 
revised it critically for important intellectual content. 
All authors have read and given approval of the final 
manuscript. Each author has participated sufficiently 
in the work to take public responsibility for appropriate 
portions of the content as described above. All authors 
agreed to be accountable for all aspects of the work 
to ensure that questions related to the accuracy or 
integrity of any part of the work would be appropriately 
investigated and resolved.
 Daud et al. EMPOWER-PAR Intervention Study
Open Access Maced J Med Sci. 2020 May 30; 8(B):470-479. 477
Acknowledgments
We would like to thank the Director General 
of Health Malaysia for his permission to publish 
this article. We are grateful to Dr Nazrila Hairizan 
Nasir, Dr Vickneswari Ayadurai, Dr Haslinda Hassan, 
Dr Salmiah Md. Sharif, Dr Naemah Sharifuddin 
Dr Rohaiyah Ismail, Dr Norhaslira Abd Rahim, 
Dr Rosnah Mat Isa, Dr Salmah Nordin, Dr Ho Bee 
Kiau and Dr Nik Suhaila Zakaria for their support and 
contribution in making the data collection and intervent.
References
1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence 
of diabetes: Estimates for the year 2000 and projections 
for 2030. Diabetes Care. 2004;27(5):1047-53. https://doi.
org/10.2337/diacare.27.5.1047
 PMid:15111519
2. Guariguata L, Whiting DR, Hambleton I, Beagley J, 
Linnenkamp U, Shaw JE. Global estimates of diabetes 
prevalence for 2013 and projections for 2035. Diabetes Res 
Clin Pract. 2014;103(2):137-49. https://doi.org/10.1016/j.
diabres.2013.11.002
 PMid:24630390
3. Nanditha A, Ma RC, Ramachandran A, Snehalatha C, Chan JC, 
Chia KS, et al. Diabetes in asia and the pacific: Implications for 
the global epidemic. Diabetes Care. 2016;39(3):472-85. https://
doi.org/10.2337/dc15-1536
 PMid:26908931
4. National Health and Morbidity Survey. Non-communicable 
Diseases, Risk Factors and other Health Problems. Vol. 2. 
National Health and Morbidity Survey; 2015. p. 1-315.
5. Feisul IM, Azmi S, Rizal AM, Zanariah H, Nik Mahir NJ, 
Fatanah I, et al. What are the direct medical costs of managing 
Type 2 diabetes mellitus in Malaysia? Med J Malaysia. 
2017;72(5):271-7.
 PMid:29197881
6. Mafauzy M, Hussein Z, Chan SP. The status of diabetes 
control in Malaysia: Results of diabcare 2008. Med J Malaysia. 
2011;66(3):175-81.
 PMid:22111435
7. International Diabetes Federation. IDF Diabetes Atlas. 
7th ed. Brussels: International Diabetes Federation; 2015. 
Available from: http://www.diabetesatlas.org. [Last accessed 
2019 Feb 15].
8. Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, 
Michaud C, et al. Disability-adjusted life years (DALYs) for 291 
diseases and injuries in 21 regions, 1990-2010: A systematic 
analysis for the global burden of disease study 2010. 
Lancet. 2012;380(9859):2197-223. https://doi.org/10.1016/
s0140-6736(12)61690-0
 PMid:23245608
9. Seidu S, Khunti K. Non-adherence to diabetes guidelines in 
primary care – the enemy of evidence-based practice. Diabetes 
Res Clin Pract. 2012;95(3):301-2. https://doi.org/10.1016/j.
diabres.2012.01.015
 PMid:22293930
10. Oh SW, Lee HJ, Chin HJ, Hwang JI. Adherence to clinical 
practice guidelines and outcomes in diabetic patients. Int J Qual 
Health Care. 2011;23(4):413-9.
 PMid:21705772
11. Barth JH, Misra S, Aakre KM, Langlois MR, Watine J, 
Twomey PJ, et al. Why are clinical practice guidelines not 
followed? Clin Chem Lab Med. 2016;54(7):1133-9. https://doi.
org/10.1515/cclm-2015-0871
 PMid:26650076
12. Chew BH, Shariff-Ghazali S, Lee PY, Cheong AT, Mastura I, 
Haniff J, et al. Type 2 diabetes mellitus patient profiles, diseases 
control and complications at four public health facilities a 
cross-sectional study based on the adult diabetes control 
and management (ADCM) registry 2009. Med J Malaysia. 
2013;68(5):397-404. https://doi.org/10.1186/1475-2840-11-54
 PMid:24632869
13. Mastura I, Chew BH, Lee PY, Cheong AT, Sazlina SG, 
Jamaiyah H, et al. Control and treatment profiles of 70,889 adult 
Type 2 diabetes mellitus patients in Malaysia a cross sectional 
survey in 2009. Int J Collab Res Intern Med Public Health. 
2011;3(1):97-113.
14. Sazlina SG, Zailinawati AH, Zaiton A, Ong I. A clinical audit 
on diabetes care in two urban public primary care clinics in 
Malaysia. Malays J Med Health Sci. 2010;6(1):101-9.
15. Ramli AS, Taher SW. Managing chronic diseases in the 
Malaysian primary health care a need for change. Malays Fam 
Phys. 2008;3(1):7-13.
16. Bodenheimer T, Wagner EH, Grumbach K. Improving primary 
care for patients with chronic illness. JAMA. 2002;288(14):1775-9. 
https://doi.org/10.1001/jama.288.14.1775
 PMid:12365965
17. Rothman AA, Wagner EH. Chronic illness management: What is 
the role of primary care? Ann Intern Med. 2003;138(3):256-61. 
https://doi.org/10.7326/0003-4819-138-3-200302040-00034
 PMid:12558376
18. Hussein Z, Taher SW, Singh HK, Swee WC. Diabetes care 
in Malaysia: Problems, new models, and solutions. Ann 
Glob Health. 2015;81(6):851-62. https://doi.org/10.1016/j.
aogh.2015.12.016
 PMid:27108152
19. Bongaerts BW, Mussig K, Wens J, Lang C, Schwarz P, Roden M, 
et al. Effectiveness of chronic care models for the management 
of Type 2 diabetes mellitus in Europe: A systematic review and 
meta-analysis. BMJ Open. 2017;7(3):e013076. https://doi.
org/10.1136/bmjopen-2016-013076 
 PMid:28320788
20. Stellefson M, Dipnarine K, Stopka C. The chronic care model 
and diabetes management in US primary care settings: 
A systematic review. Prev Chronic Dis. 2013;10:26. https://doi.
org/10.5888/pcd10.120180
 PMid:23428085
21. Nutting PA, Dickinson WP, Dickinson LM, Nelson CC, King DK, 
Crabtree BF, et al. Use of chronic care model elements is 
associated with higher-quality care for diabetes. Ann Fam Med. 
2007;5(1):14-20. https://doi.org/10.1370/afm.610
 PMid:17261860
22. Barletta V, Profili F, Gini R, Grilli L, Rampichini C, Matarrese D, 
et al. Impact of chronic care model on diabetes care in tuscany: 
A controlled before-after study. Eur J Public Health. 2017;27(1):8-
13. https://doi.org/10.1093/eurpub/ckw189 PMid:28177456
23. Ku GM, Kegels G. Implementing elements of a context-adapted 
chronic care model to improve first-line diabetes care: Effects 
on assessment of chronic illness care and glycaemic control 
among people with diabetes enrolled to the first-line diabetes 
care (FiLDCare) project in the Northern Philippines. Prim Health 
Care Res Dev. 2015;16(5):481-91. https://doi.org/10.1017/
B - Clinical Sciences Endocrinology
478 https://www.id-press.eu/mjms/index
s1463423614000553
 PMid:25600305
24. Ramli AS, Selvarajah S, Daud MH, Haniff J, Abdul-Razak S, 
Tg-Abu-Bakar-Sidik TM, et al. Effectiveness of the EMPOWER-
PAR intervention in improving clinical outcomes of Type 2 
diabetes mellitus in primary care: A pragmatic cluster 
randomised controlled trial. BMC Fam Pract. 2016;17(1):157. 
https://doi.org/10.1186/s12875-016-0557-1
 PMid:27842495
25. Ramli AS, Lakshmanan S, Haniff J, Selvarajah S, Tong SF, 
Bujang MA, et al. Study protocol of EMPOWER Participatory 
Action Research (EMPOWER-PAR): A pragmatic cluster 
randomised controlled trial of multifaceted chronic disease 
management strategies to improve diabetes and hypertension 
outcomes in primary care. BMC Fam Pract. 2014;15(1):151. 
https://doi.org/10.1186/1471-2296-15-151
 PMid:25218689
26. Ministry of Health. Clinical Practice Guideline on Management 
of Type 2 Diabetes Mellitus. 5th ed. Malaysia: Ministry of 
Health; 2015. Available from: http://www.moh.gov.my/moh/
resources/Penerbitan/CPG/Endocrine/3a.pdf. [Last accessed 
on 2019 Feb 18].
27. Rushforth B, McCrorie C, Glidewell L, Midgley E, Foy R. Barriers 
to effective management of Type 2 diabetes in primary care: 
Qualitative systematic review. Br J Gen Pract. 2016;66(643):114-
27. https://doi.org/10.3399/bjgp16x683509 PMid:26823263
28. van Bruggen R, Gorter KJ, Stolk RP, Verhoeven RP, Rutten GE. 
Implementation of locally adapted guidelines on Type 2 
diabetes. Fam Pract. 2008;25(1):430-7. https://doi.org/10.1093/
fampra/cmn045
 PMid:18718886
29. Bertoni AG, Bonds DE, Chen H, Hogan P, Crago L, 
Rosenberger E, et al. Impact of a multifaceted intervention 
on cholesterol management in primary care practices. Arch 
Intern Med. 2009;169(7):678-86. https://doi.org/10.1001/
archinternmed.2009.44
 PMid:19364997
30. Putnam LR, Levy SM, Sajid M, Dubuisson DA, Rogers NB, 
Kao LS, et al. Multifaceted interventions improve adherence to 
the surgical checklist. Surgery. 2014;156(2):336-44. https://doi.
org/10.1016/j.surg.2014.03.032
 PMid:24947646
31. Godwin M, Ruhland L, Casson I, MacDonald S, Delva D, 
Birtwhistle R, et al. Pragmatic controlled clinical trials in 
primary care: The struggle between external and internal 
validity. BMC Med Res Methodol. 2003;3(1):28. https://doi.
org/10.1186/1471-2288-3-28
 PMid:14690550
32. Samoutis GA, Soteriades ES, Stoffers HE, Philalithis A, 
Delicha EM, Lionis C. A pilot quality improvement intervention 
in patients with diabetes and hypertension in primary care 
settings of Cyprus. Fam Pract. 2010;27(3):263-70. https://doi.
org/10.1093/fampra/cmq009
 PMid:20348163
33. Zgibor JC, Rao H, Wesche-Thobaben J, Gallagher N, 
McWillinms J, Korytkozuski MT. Improving the quality of diabetes 
care in primary care practice. J Healthc Qual. 2004;26(4):14-21. 
https://doi.org/10.1111/j.1945-1474.2004.tb00502.x
 PMid:15352340
34. Jeffery RA, To MJ, Hayduk-Costa G, Cameron A, Taylor C, 
Van Zoost C, et al. Interventions to improve adherence to 
cardiovascular disease guidelines: A systematic review. 
BMC Fam Pract. 2015;16(1):147. https://doi.org/10.1186/
s12875-015-0341-7
 PMid:26494597
35. English M, Nzinga J, Mbindyo P, Ayieko P, Irimu G, Mbaabu L. 
Explaining the effects of a multifaceted intervention to improve 
inpatient care in rural Kenyan hospitals--interpretation 
based on retrospective examination of data from participant 
observation, quantitative and qualitative studies. Implement Sci. 
2011;6(1):124. https://doi.org/10.1186/1748-5908-6-124
 PMid:22132875
36. Satman I, Imamoglu S, Yilmaz C, Admire Study Group. A patient-
based study on the adherence of physicians to guidelines for the 
management o
f Type 2 diabetes in Turkey. Diabetes Res Clin Pract. 2012;98(1):75-
82. https://doi.org/10.1016/j.diabres.2012.05.003
 PMid:22652276
37. Farquhar CM, Kofa EW, Slutsky JR. Clinicians’ attitudes to 
clinical practice guidelines: A systematic review. Med J Aust. 
2002;177(9):502-6. https://doi.org/10.5694/j.1326-5377.2002.
tb04920.x
 PMid:12405894
38. Lesho EP, Myers CP, Ott M, Winslow C, Brown JE. Do clinical 
practice guidelines improve processes or outcomes in primary 
care? Mil Med. 2005;170(3):234-46. https://doi.org/10.7205/
milmed.170.3.243
 PMid:15828703
 Daud et al. EMPOWER-PAR Intervention Study
Open Access Maced J Med Sci. 2020 May 30; 8(B):470-479. 479
Appendix 
Appendix 1. The Indicators of care proforma 
Section Indicators of Care 
History 1.  Family history of premature CVD was recorded once since diagnosis 
(yes/no) 
2. Smoking status was recorded at least once in the last 1 year (yes/no) 
3.  Presence or absence of erectile dysfunction was screened and 
recorded in adult males over the age of 40 years (yes/no) 
Physical 
examinations 
4. Blood pressure (BP) was recorded at each visit (yes/no) 
5.  Body mass index (BMI) was recorded at least once in the last 1 year 
(yes/no) 
6.  Waist circumference (WC) was recorded at least once in the last 1 
year (yes/no) 
7.  Foot examination was performed at least once in the last 1 year (yes/no) 
Investigations 8.  Fasting Serum Lipid (FSL) was measured at least once in the last 1 
year (yes/no) 
9. HbA1c was measured every 6-12 months (yes/no) 
10.  Funduscopy/fundus photography was performed at least once in the 
last 1 year (yes/no) 
11. ECG was performed at least once in the last 1 year (yes/no) 
12.  Renal Profile (RP) was measured at least once in the last 1 year 
(yes/no) 
